Pages

Service Providers

Find a Service Provider Global network of recommended service providers for Bruker Cellular Analysis platforms Speed Access the Bruker Cellular Analysis platforms today through one of our service providers so you can get to the data faster and expedite your research. Confidence All recommended service providers have been trained by Bruker Cellular Analysis on the […]

Service Providers Read More »

Antibody Discovery – Opto® B Discovery Application

Opto B Discovery ApplicationFuel Antibody Discovery Breakthroughs with Function-First Screening Overview Capabilities Technology Resources OVERVIEWPowering Your Success in Single B Cell Antibody Discovery with the Opto® B Discovery Application Opto B Discovery on the Beacon® platform revolutionizes antibody discovery (AbD) with its function-first, high-throughput single B cell screening, maximizing the success of your antibody campaigns.​​

Antibody Discovery – Opto® B Discovery Application Read More »

Cell Analysis Suite Software 3.2

Cell Analysis Suite SoftwareDynamic Instrument Control and Data Analysis for Beacon® Optofluidic Platform Design and execute single cell experiments in real-time with unparalleled flexibility to generate and analyze functional data at scale. Download Datasheet Empower Live Single Cell Multiomics The Cell Analysis Suite (CAS®) is powerful software designed for the Beacon Optofluidic Platform, enabling researchers

Cell Analysis Suite Software 3.2 Read More »

Opto® B Discovery Affinity Assay

Opto B Discovery Affinity Assay: Transforming Antibody DiscoveryBoost Your Hit Generation with Early AntibodyAffinity Ranking Get in Touch Overview How It Works Resources OVERVIEWEarly Ranking, Better Outcomes: Relatively Rank Antibody Hits with the Opto® B Discovery Affinity Assay Optimize your antibody discovery process with the innovative Opto® B Discovery Affinity Assay. This cutting-edge tool allows

Opto® B Discovery Affinity Assay Read More »

Accelerating Antibody Discovery and Cell Therapy with Beacon® Platform Seminar

Oxford, England Accelerating Antibody Discovery and Cell Therapy with Beacon® Platform Seminar Date 25 September 2024 Time 12-5 PM Including Lunch Venue University of Oxford, Department of Biochemistry, South Parks Road, Oxford OX1 3QU Dietary Restrictions For dietary restrictions, please fill out the separate Dietary Restrictions form after registering. Event Registration Form Meet the Beacon®

Accelerating Antibody Discovery and Cell Therapy with Beacon® Platform Seminar Read More »

T Cell Profiling Kit

Optofluidic ChipsT Cell Profiling Kit Thoroughly profile single T cells and link their phenotypic and functional data to their genotypes. Download Product Sheet Overview Technology Products Research & Data Get in Touch OVERVIEWT Cell Profiling Kit, a Comprehensive Solution That Empowers You to Thoroughly Profile Single T Cells and Link Their Phenotypic and Functional Data

T Cell Profiling Kit Read More »

Cell Line Development Kit

Optofluidic ChipsCell Line Development Kit Streamline and expedite your cell line development process. Download Product Sheet Overview Technology Products Research & Data Get in Touch OVERVIEWA Next Generation Solution That Streamlines and Expedites the Cell Line Development Process Select high-titer clones and the best cells, significantly increasing your productivity when compared to traditional methods. Boost

Cell Line Development Kit Read More »

Antibody Discovery Kit

Optofluidic ChipsAntibody Discovery Kit Human / Mouse / Rabbit A powerful automated solution for faster, more precise Antibody Discovery Download Product Sheet Overview Technology Products Research & Data Get in Touch OVERVIEWAdvanced Reagents and Chips that Streamline Monoclonal Antibody Discovery Our best-in-class reagents and chips let you screen plasma cells or memory B cells and find

Antibody Discovery Kit Read More »

Amgen on Antibody Discovery and Cell Line Development

Customer SpotlightAmgen on Antibody Discovery and Cell Line Development CUSTOMER QUOTE“In the long run, this technology will help us to solve complex problems that are too hard or expensive to solve with our current tools.” — Philip Tagari, Vice President of Therapeutic Discovery, Amgen TRANSFORMATIVE TECHNOLOGY As one of the early customers to have adopted

Amgen on Antibody Discovery and Cell Line Development Read More »